Top Markets
#1 TENDIES TENDIES +54.24%
#2 Threshold Network Threshold Network +49.23%
#3 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#4 OSK OSK +16.47%
#5 Kinetiq Kinetiq +15.86%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Kite Kite +12.06%
#8 Maple Finance Maple Finance +12.00%
#9 Mubarak Mubarak +11.90%
#10 Magma Finance Magma Finance +11.37%
Coin of the day
TENDIES TENDIES
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Classement en actions #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Prix de l'action
$1.33
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$246.43M
Changement (1 jour)
0.00%
Changement (1 an)
-23.56%
Pays
US
Échange Neumora Therapeutics, Inc. Common Stock (NMRA)

Catégorie

Healthcare
Historique du prix de l'action pour Neumora Therapeutics, Inc. Common Stock (NMRA)
Prix de clôture le plus élevé : $1.35 le 2026-09-01

Prix de clôture le plus bas : $12.50 le 2023-09-01
Historique du prix de l'action de Neumora Therapeutics, Inc. Common Stock de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.65 37.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.27%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.50 513.89%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $763.69 9.05%
CH